Debate: What is the Optimal Neoadjuvant Strategy in Pancreatic Cancer?

Debate: What is the Optimal Neoadjuvant Strategy in Pancreatic Cancer?

User Photo
GiDebates2017

3 years
837 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Christopher Crane, MD of Memorial Sloan-Kettering gives an overview of his presentation, What is the Optimal Neoadjuvant Strategy in Pancreatic Cancer, which was debated at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
Up Next Autoplay